• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bioatla Inc (NQ: BCAB )

    1.320 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 1.320
    Bid (Size) 1.250 (1)
    Ask (Size) 1.410 (4)
    Prev. Close 1.320
    Today's Range 1.320 - 1.320
    52wk Range 1.240 - 4.020
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BCAB Stock Earnings: BioAtla Beats EPS for Q1 2024
    BCAB stock results show that BioAtla beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga

    Performance

    YTD
    -50.19%
    -50.19%
    1 Month
    -16.98%
    -16.98%
    3 Month
    -62.50%
    -62.50%
    6 Month
    -50.19%
    -50.19%
    1 Year
    -55.10%
    -55.10%

    More News

    Read More
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    BCAB Stock Earnings: BioAtla Beats EPS for Q4 2023
    Via InvestorPlace
    BioAtla: Q4 Earnings Insights
    Via Benzinga
    Preview: BioAtla's Earnings
    Via Benzinga
    Analyst Ratings for BioAtla
    Via Benzinga
    The Latest Analyst Ratings for BioAtla
    Via Benzinga
    Earnings Scheduled For March 26, 2024
    Via Benzinga
    Around $2M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
    From BioAtla, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event
    From BioAtla, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    BioAtla to Participate in the JMP Securities Hematology and Oncology Summit
    From BioAtla, Inc.
    Via GlobeNewswire
    BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC
    From BioAtla, Inc.
    Via GlobeNewswire
    BioAtla Reports Third Quarter 2023 Financial Results and Highlights Recent Progress
    From BioAtla, Inc.
    Via GlobeNewswire
    BioAtla to Participate in the Jefferies London Healthcare Conference
    From BioAtla, Inc.
    Via GlobeNewswire
    BioAtla’s Jay M. Short, Ph.D., Selected for The Explorers Club Lowell Thomas Award
    From BioAtla, Inc.
    Via GlobeNewswire
    BioAtla Provides Guidance on Near-Term Milestones and Plans to Announce Third Quarter 2023 Financial Results and Business Update on November 7, 2023
    From BioAtla, Inc.
    Via GlobeNewswire
    BioAtla to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
    From BioAtla, Inc.
    Via GlobeNewswire
    BioAtla to Participate in Upcoming Investor Conferences in August
    From BioAtla, Inc.
    Via GlobeNewswire
    BioAtla Reports Second Quarter 2023 Financial Results and Highlights Recent Progress
    From BioAtla, Inc.
    Via GlobeNewswire
    BioAtla to Announce Second Quarter 2023 Financial Results and Provide Business Highlights on August 1, 2023
    From BioAtla, Inc.
    Via GlobeNewswire
    BioAtla Added to Membership of U.S. Small-Cap Russell 2000® Index
    From BioAtla, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.